- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03783884
A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation (RESCUE3)
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
This clinical investigation is an open-label, multi-center RCT to demonstrate the safety and effective performance of the Lungpacer DPTS (plus standard of care) as compared to Control (standard of care only) in patients aged 18 years or older who are receiving mechanical ventilation. Eligible Subjects will have received mechanical ventilation for ≥96 hours (4 days) and failed two weaning attempts.
The goal or outcome is to show a numerically greater proportion of subjects weaned in the Treatment (Lungpacer DPTS) group as compared to the Control group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Angers, France, 49933
- CHU Angers
-
Montpellier, France, 34295
- CHU Montpellier
-
Paris, France, 75651
- Hôpital La Pitié-Salpétrière
-
Strasbourg, France, 67091
- CHU Strasbourg
-
-
-
-
-
Berlin, Germany, 10117
- Berlin Charite Mitte
-
Essen, Germany, 45276
- KEM Essen
-
Löwenstein, Germany, 74245
- SLK Löwenstein
-
Nürnberg, Germany, 90419
- Nürnberg Klinikum Nord
-
Schmallenberg, Germany, 57392
- FKKG Schmallenberg
-
Solingen, Germany, 42699
- Solingen Krankenhaus Bethanien
-
-
Mecklenburg-Vorpommern
-
Greifswald, Mecklenburg-Vorpommern, Germany, 17475
- Universitätsmedizin Greifswald
-
-
-
-
California
-
Stanford, California, United States, 94305
- Stanford University Medical Center
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of COlorado Anschutz Medical Campus
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida, Shands
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Chicago, Illinois, United States, 60611
- Northwestern University Feinberg School of Medicine
-
Chicago, Illinois, United States, 60612
- U of Illinois at Chicago
-
Hines, Illinois, United States, 60141
- Edward Hines VA Hospital
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University Health Methodist Hospital
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville
-
-
Massachusetts
-
Burlington, Massachusetts, United States, 01805
- Lahey Hospital and Medical Center
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Minneapolis Heart Institute Foundation
-
-
Nebraska
-
Omaha, Nebraska, United States, 68124
- CHI Health Creighton University Medical Center - Bergan Mercy
-
-
New Jersey
-
Englewood, New Jersey, United States, 07631
- Englewood Hospital Medical Center
-
-
Ohio
-
Cincinnati, Ohio, United States, 45267
- University of Cincinnati
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, United States, 43210
- Ohio State University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
-
Rhode Island
-
Warwick, Rhode Island, United States, 02886
- Kent County Memorial Hospital
-
-
South Carolina
-
Columbia, South Carolina, United States, 29203
- Prisma Health Baptist Hospital
-
-
Texas
-
Dallas, Texas, United States, 75390
- University of Texas Southwestern, Zale Lipshy Hospital
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Are 18 years or older, and,
- Have been mechanically ventilated for ≥96 hours (4 days), and,
- Have satisfied the Readiness-to-Wean criteria, and,
- Have failed at least 2 weaning attempts (that were conducted at least 48 hours after initiation of MV, and, that were conducted on different calendar days, and, at least one of which was the protocol-specific Ventilator Liberation Trial).
Exclusion Criteria:
- MIP (absolute value) >50 cm H2O;
- Invasive mechanical ventilation >90 days;
- Currently on ECMO;
- Weaning failure due to hypervolemia;
- Medical history (including imaging) or known anatomy that prevents percutaneous insertion of the Catheter into the intended thoracic vein on the left side.
- Clinically overt congestive heart failure that is preventing weaning;
- Currently being treated with neuromuscular blockade;
- Pre-existing neurological, neuromuscular or muscular disorder that could affect the respiratory muscles;
- Pre-existing severe chronic pulmonary fibrosis;
- Pleural effusions occupying greater than one third of the pleural space on either side;
- BMI >45 kg/m2;
- Known or suspected phrenic nerve paralysis;
- Any electrical device (implanted or external) that may be prone to interaction with, or interference from the Lungpacer DPTS including neurological pacing/stimulator devices, cardiac pacemakers and defibrillators;
- Current hemodynamic instability, sepsis or septic shock;
- Prior bacteremia reported within the last 48 hours;
- Anticipating withdrawal of life support and/or shift to palliation as the goal of care;
- Known or suspected to be pregnant or lactating;
- Currently being treated in another clinical trial studying an experimental treatment that could affect the study primary outcome.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Treatment
Subject receives Lungpacer Catheter for transvenous phrenic nerve stimulation to deliver Diaphragm Pacing Therapy Sessions.
DPT sessions are 6 sets of 10, delivered twice daily, for a total of 120 stimulation reps per day, plus standard of care for weaning from mechanical ventilation.
|
Transvenous phrenic nerve stimulation to induce diaphragm contraction.
Other Names:
|
NO_INTERVENTION: Control
Subject does not receive Lungpacer Catheter or DPT.
Subject receives only Standard of care for weaning from mechanical ventilation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful wean
Time Frame: 30 days
|
The proportion of subjects who are successfully weaned will be statistically significantly greater for subjects randomized to Treatment (Lungpacer DPTS) compared to subjects randomized to Control.
|
30 days
|
Maximal Inspiratory Pressure mean change
Time Frame: 30 days
|
The MIP mean change from baseline will be statistically significantly greater for subjects randomized to Lungpacer DPTS compared to subjects randomized to Control.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Rapid Shallow Breathing Index (RSBI)
Time Frame: 30 days
|
Change in RSBI over time from randomization (baseline)
|
30 days
|
Mortality
Time Frame: 30 days
|
To compare Treatment (Lungpacer DPTS) subjects to Control subjects for Day 30 mortality.
|
30 days
|
Rate of RSBI Change
Time Frame: 30 days
|
Rate of RSBI change per day from randomization (baseline) to last available measure
|
30 days
|
Rate of MIP Change
Time Frame: 30 days
|
Rate of MIP change per day from randomization (baseline) to last available measure;
|
30 days
|
Change in MIP
Time Frame: 30 days
|
Change in MIP over time from randomization (baseline)
|
30 days
|
Days on MV
Time Frame: Successful weaning or day 30
|
Days on mechanical ventilation from Day 1 to removal from MV associated with successful weaning or Day 30, whichever comes first.
|
Successful weaning or day 30
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse Event Assessment
Time Frame: 30 days
|
Adverse events for subjects randomized to Treatment (Lungpacer DPTS) as compared to subjects randomized to Control.
|
30 days
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P-300
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Induced Diaphragm Dysfunction
-
Synapse BiomedicalCompletedVentilator-Induced Diaphragm DysfunctionUnited States
-
Stimdia Medical Inc.RecruitingVentilator Induced Diaphragm DysfunctionUnited States
-
Synapse BiomedicalActive, not recruitingVentilator Induced Diaphragm DysfunctionUnited States
-
University Hospital, AntwerpCompletedVentilator-induced Diaphragm Dysfunction | VIDDBelgium
-
Lungpacer Medical Inc.SyntactxCompletedVentilator Induced Diaphragm DysfunctionUnited States
-
Lungpacer Medical Inc.SyntactxCompletedVentilator Induced Diaphragm DysfunctionGermany, France
-
Children's Hospital of Fudan UniversityRecruitingMechanical Ventilation Complication | Ventilator-induced Diaphragm DysfunctionChina
-
Stimdia Medical, Inc.Completed
-
Institut de Myologie, FranceRecruitingDiaphragm DysfunctionFrance
-
Seoul National University HospitalCompletedDiaphragm DysfunctionKorea, Republic of
Clinical Trials on Lungpacer Diaphragm Pacing Therapy
-
Lungpacer Medical Inc.CompletedAcute Respiratory Distress Syndrome | Ventilation Therapy; ComplicationsFrance
-
Lungpacer Medical Inc.SyntactxCompletedVentilator Induced Diaphragm DysfunctionUnited States
-
Synapse BiomedicalCompletedAmyotrophic Lateral Sclerosis (ALS)United States
-
University of FloridaNational Institutes of Health (NIH)Completed
-
University of FloridaThe Craig H. Neilsen Foundation; Brooks RehabilitationCompleted
-
Synapse BiomedicalCompletedChronic Obstructive Airway DiseaseBelgium
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingCritically Ill | Mechanical Ventilation | Early Mobilization | Diaphragm Dysfunction
-
Synapse BiomedicalWithdrawnTracheostomy | Ventilator-Induced Lung Injury | Diaphragm IssuesTurkey
-
Synapse BiomedicalWithdrawnAmyotrophic Lateral Sclerosis
-
Zhang liqiongSuspendedStroke | Respiratory FunctionChina